Leland Gershell Net Worth & Insider Trades

Leland Gershell - CHIEF FINANCIAL OFFICER, Capricor Therapeutics, Inc

As of March 18, 2016

What is Leland Gershell's Net Worth?

The current estimated net worth of Capricor Therapeutics, Inc's CHIEF FINANCIAL OFFICER, Leland Gershell, is estimated to be about $17.54K . Leland Gershell owns about 2,100 units of Capricor Therapeutics, Inc common stock. In the last month at Capricor Therapeutics, Inc, Leland Gershell has sold an estimated value of $0 worth.

What is Leland Gershell's Past Insider Trading?

Leland Gershell's largest purchase order was 2,100 units , worth over $5.04K on March 18, 2016. In total, Leland Gershell has made about 2 transactions over a month of their time at Capricor Therapeutics, Inc. Leland Gershell usually trades in March, with the busiest year in 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LELAND GERSHELL

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Leland Gershell's' Mailing Address?

  • Mailing address is C/o Tonix Pharmaceuticals Holding Corp 509 Madison Ave., Ste 306 New York NY 10022 NY

Capricor Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Linda Marbán, Ph.D. 2019 $156,909 - $70,510 $1,500 $228,919
Linda Marbán, Ph.D. 2020 $150,000 $45,000 $1,460,532 $1,500 $1,657,032
Karen Krasney, J.D. 2019 $300,000 - $38,827 $1,500 $340,327
Karen Krasney, J.D. 2020 $313,750 $31,500 $415,855 $1,500 $762,605
Anthony Bergmann 2019 $212,500 - $38,827 $1,500 $252,827
Anthony Bergmann 2020 $287,500 $27,500 $475,692 $1,500 $792,192
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1133869/000110465921052552/tm212634d1_def14a.htm

What are Capricor Therapeutics, Inc's Past Insider Trades?

Capricor Therapeutics, Inc's most recent insider trade came on October 13, 2023 by David Musket who bought 410 units worth $1.13K . In the last 8 years, insiders at Capricor Therapeutics, Inc have sold an estimated value of $1.04M and bought an estimated value of $16.3M worth of shares. Insider trading is most common in January, with the busiest year in 2023. The most active traders at the company are David Musket,  Louis Manzo,  and Earl Collier Jr .

CAPRICOR THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...